NEW YORK (GenomeWeb News) – Celera, which is scheduled to officially split tomorrow from parent firm Applera and sister company Applied Biosystems, has registered to have its shares float on the Nasdaq Stock Market.
 
The firm’s shares currently trade as a tracking stock of Applera on the New York Stock Exchange. Its stock will be delisted from the New York Stock Exchange when the split is finalized.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A University of California, Los Angeles-led team has found turning off the CCR5 gene could improve recovery after a stroke, according to Scientific American.

South Dakota lawmakers are to weigh a bill aimed at teaching the strengths and weaknesses of scientific concepts, the Associated Press and KEVN-Black Hills Fox report.

In Science this week: the synthetic genetic system hachimoji, and more.

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.